News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major market-moving headlines emerged in the past hour.
  • Global equity and bond markets showed little movement absent fresh catalysts.
  • No significant economic data releases were reported in the past hour.
  • No central bank announcements or policy actions occurred during the hour.
  • No geopolitical events or emergency developments were reported in the past hour.
  • Corporate news flow was quiet with no material earnings or M&A headlines.
  • Liquidity conditions remained stable with no spikes in volatility or risk indicators.

Latest Articles

Elliott Poised to Profit if Patrick Drahi Proceeds with SFR Sale

Elliott Poised to Profit if Patrick Drahi Proceeds with SFR Sale

Elliott Investment Management holds multiple positions in the Altice group that would produce gains if Patrick Drahi advances a planned sale of French telecom operator SFR. The firm is both a shareholder after a 2025 debt-to-equity conversion and a creditor whose loans contain change-of-control repayment triggers. An additional secured loan tied to…

Ghana’s economy grows 6.4% in Q1 2026 as services and industry drive expansion

Ghana’s economy grows 6.4% in Q1 2026 as services and industry drive expansion

Ghana recorded 6.4% year-on-year economic growth in the first quarter of 2026, up from a revised 6.2% in Q1 2025, driven by gains in the services and industrial sectors. Government statisticians highlighted ongoing expansion coupled with improved price stability. Agriculture continues to play a key role in employment and food security, while inflat…

Polyrizon Receives Notice of European Patent Publication for Innovative Mucoadhesive Nasal Drug Delivery Technology

Polyrizon Receives Notice of European Patent Publication for Innovative Mucoadhesive Nasal Drug Delivery Technology

Polyrizon Ltd., a development-stage biotech company specializing in innovative nasal hydrogel technologies, announced the European Patent Office's completion of technical preparations for publication of its European patent application covering its Trap & Target™ mucoadhesive polymer platform. This technology aims to improve nasal drug delivery by i…

Volvo shares dip after Capital Markets Day as analyst keeps cautious stance

Volvo shares dip after Capital Markets Day as analyst keeps cautious stance

Volvo AB shares fell just over 3% after the company held its Capital Markets Day in Eskilstuna, where management reiterated ambitious growth targets across trucks, construction equipment, autonomous solutions and marine engines. Morgan Stanley retained an "equal-weight" rating and a SEK 342 price target, saying the group's quality is largely reflec…

Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success

Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success

Artelo Biosciences presented favorable human metabolite data for its lead drug candidate ART26.12, demonstrating a low-risk metabolism profile with only three metabolites at low plasma levels. These metabolites are consistent with nonclinical species and present no safety concerns. The findings support ART26.12's continued clinical development as a…

Porsche Says No to a Fully Electric 911

Porsche Says No to a Fully Electric 911

Porsche CEO Michael Leiters stated at an event hosted by the magazine "Auto, Motor und Sport" that the company will not build a fully electric version of its iconic 911 sports car. Leiters reiterated that, to date, all 911 variants have been combustion-engine vehicles, with some available as hybrids. Porsche already offers a fully electric sports c…

Trump Warns Iran Will 'Pay the Price' as Negotiations Stall and Strikes Continue

Trump Warns Iran Will 'Pay the Price' as Negotiations Stall and Strikes Continue

President Donald Trump said Iran has delayed signing a deal for too long and warned the country would "have to pay the price" as the two sides traded attacks in the region. Trump indicated he was close to ordering strikes on Iranian infrastructure if Tehran does not agree. Meanwhile, an official said Qatari negotiators flew to Tehran on Wednesday m…

PMGC Holdings Highlights Advanced Precision Manufacturing Capabilities Supporting Space Exploration Supply Chains

PMGC Holdings Highlights Advanced Precision Manufacturing Capabilities Supporting Space Exploration Supply Chains

PMGC Holdings Inc. highlights the strategic positioning of its precision manufacturing subsidiaries—A&B Aerospace, SVM Machining, and AGA Precision Systems—to support the expanding space exploration economy. Certified and ITAR-registered, these companies offer critical CNC machining and complex component manufacturing capabilities aligned with aero…

Creative Realities to Participate in Upcoming Planet MicroCap Event

Creative Realities to Participate in Upcoming Planet MicroCap Event

Creative Realities, Inc. (NASDAQ: CREX), a digital signage and AdTech company, announced its participation in the Planet MicroCap Showcase Conference in Las Vegas on June 17-18, 2026. The company will provide a live webcast presentation and hold investor meetings to discuss its operations, including integration of recent acquisitions and growth str…

Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C

Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C

Rafael Holdings announced completion of the last patient visit in its pivotal Phase 3 TransportNPC study evaluating Trappsol® Cyclo™ for Niemann-Pick Disease Type C. The company expects to announce topline results and submit a New Drug Application (NDA) to the FDA in the second half of 2026. The FDA has acknowledged the company's US Expanded Access…

Bread Financial Provides Performance Update for May 2026

Bread Financial Provides Performance Update for May 2026

Bread Financial Holdings, Inc. announced its performance update for May 2026, showing a 2.6% increase in average credit card and other loans compared to the previous year. The company reported a decrease in net principal loss rate down to 6.98% from 7.97%, and a reduction in delinquency rate to 5.24% from 5.71%, evidencing improved credit quality. …

CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies

CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies

CervoMed announced a $10.5 million private placement financing to extend its cash runway into Q2 2027 and support strategic partnering efforts to advance its lead drug candidate, neflamapimod, into Phase 3 clinical trials for dementia with Lewy bodies (DLB). The company also provided updates on its pipeline, including ongoing Phase 2a trials in non…

Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases

Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases

Cullinan Therapeutics presented promising clinical data from its T cell engager portfolio, including CLN-978 and velinotamig, targeting CD19 and BCMA respectively, in autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The data show potential for immune reset, clinical remissions, and favorable safety profi…

FirstService Broadens Commercial Roofing Geographic Footprint

FirstService Broadens Commercial Roofing Geographic Footprint

FirstService Corporation announced that its subsidiary Roofing Corp of America acquired Schefers Roofing, a full-service commercial roofing contractor in Kansas City, expanding its geographic presence in the Midwest U.S. region. The existing management of Schefers retains a minority interest and continues operations.